Clinical trials using genetic analysis are forecasted to be 3.5 months quicker in 2025
For biopharmaceutical developers, optimizing R&D investment in new technologies is an essential way to gain and sustain a competitive edge. Clinical trials present a tremendous opportunity to leverage advanced genetics technologies and practices to improve efficiency and reduce costs.
Stay ahead of the curve and download the report to learn:
- How genetic analysis is enabling more rapid and efficient clinical trials
- How integration of genetic analysis technologies is evolving in the pharma and biotech spaces
- How companies around the world are deploying genetic analysis to gain competitive advantage
